Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix

Cancer

Volumn 92, Issue 9, 2001, Pages 2327-2333

  Verschraegen, Claire F ^a,b   Kavanagh, John J ^a   Loyer, Evelyne ^a   Bodurka Bevers, Diane ^a   Kudelka, Andrzej P ^a   Hu, Wei ^a   Vincent, Monique ^a   Nelson, Tarra ^a   Levenback, Charles ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Sect Gynecologic Med Therapeut   (United States)

Author keywords

Carboplatin; Cervix neoplasms; Doxorubicin; Phase II

Indexed keywords

CARBOPLATIN; DOXORUBICIN;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG FORMULATION; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; STOMATITIS; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LIPOSOMES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0035498749     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011101)92:9<2327::AID-CNCR1579>3.0.CO;2-6     Document Type: Article

References (23)

1. Epidemiology and biology of cervical cancer
2. Current developments in the treatment of newly diagnosed cervical cancer
3. Chemotherapy for cervical carcinoma: Factors determining response and implications for clinical trial design
4. Chemotherapy of advanced and recurrent cervical carcinoma
5. Single-agent chemotherapy for recurrent carcinoma of the cervix
6. Bleomycin-Adriamycin-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent cervical carcinoma
7. Cancer of the uterine cervix
8. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma
9. Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
10. Clinical studies of liposome-encapsulated doxorubicin
11. Carcinoma of the uterine cervix: Current status and future directions
12. Interactions of doxorubicin and cis-platin in squamous carcinoma cells in culture
13. Pharmacokinetics and tumor localization of Dox-SL (stealth liposomal doxorubicin) by comparison with Adriamycin in patients with AIDS and Kaposi's sarcoma
14. Reporting results of cancer treatment
15. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynecologic Oncology Group study
16. Polyethylene glycol-liposomal doxorubicin
17. Cancer of the cervix, vagina and vulva
18. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study
19. Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
20. A Phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix
21. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - A Phase II study
22. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A gynecologic oncology group study
23. Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease